Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 2 H
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp CRISPR
NF28-29/30 (whole-mount microscopy)
|
|
|
|
FIg. 2 M
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp CRISPR
NF40-41 (whole-mount microscopy)
|
|
|
|
Fig. 2 I
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp CRISPR2
NF28-29/30 (whole-mount microscopy)
|
|
|
|
Fig. 2 N
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp CRISPR2
NF40-41 (whole-mount microscopy)
|
|
|
|
Fig. 2 F
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp MO
NF28-29/30 (whole-mount microscopy)
|
|
skin disease
|
|
Fig. 2 F
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp MO
NF28-29/30 (whole-mount microscopy)
|
|
skin disease
|
|
Fig. 2 K
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp MO
NF40-41 (whole-mount microscopy)
|
|
skin disease
|
|
Fig. 2 L
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + dsp MO
NF40-41 (whole-mount microscopy)
|
|
skin disease
|
|
Fig. 7 D
Bharathan NK and Dickinson AJG (2019)
|
Xla Wt + Hsa.DSPdel
NF28-29/30 (whole-mount microscopy)
|
|
skin disease
|